Crossmark

Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial

Crossref DOI link: https://doi.org/10.1245/s10434-017-5814-6

Published Online: 2017-02-21

Published Print: 2017-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Frøysnes, Ida S.

Andersson, Yvonne

Larsen, Stein G.

Davidson, Ben

Øien, Janne-Merete Torset

Olsen, Kari Hauge

Giercksky, Karl-Erik

Julsrud, Lars

Fodstad, Øystein

Dueland, Svein

Flatmark, Kjersti
License Information

License valid from 2017-02-21